CD8A and nonpapillary renal cell carcinoma: Taken together, our immune infiltration analyses suggest that these YDC-associated biomarkers may influence ccRCC patient survival by modulating the immune microenvironment, particularly through the regulation of CD8+ T cells, Tregs, and M1 macrophages.